Drugs in ATC Class V04CK

Up to Top Level ATC Classes

Up to V - Various

Up to V04 - DIAGNOSTIC AGENTS

Up to V04C - OTHER DIAGNOSTIC AGENTS

Drugs in ATC Class: V04CK - Tests for pancreatic function

Tradename	Generic Name
SECRETIN-FERRING	secretin
CHIRHOSTIM	secretin synthetic human
SECREFLO	secretin synthetic porcine
CHYMEX	bentiromide

Market dynamics and patent landscape for ATC Class V04CK “Tests for pancreatic function”

Last updated: July 12, 2026

Executive summary: ATC V04CK is a diagnostic ATC class covering pancreatic function tests rather than a therapeutic drug category. Market dynamics are driven by (1) regulatory approval pathways for in vitro vs in vivo diagnostic agents, (2) reimbursement and hospital procurement cycles, and (3) utilization protocols tied to specific analyzers, imaging platforms, and labeled test kits or dosing regimens. The patent landscape is typically dominated by method-of-use claims (clinical protocols and interpretation), device-and-kit claims (formulations, reagents, calibrators, stability), and sometimes manufacturing/sterility/process claims for diagnostic reagents. In contrast to pharmaceutical exclusivity models, diagnostic exclusivity and patent enforceability hinge on labeling, composition claims, and logistics of replacement across sites of care.

Hard-data constraint: No drug/product list, national filings, or Orange Book / EP register / USPTO application family identifiers were provided for V04CK. Without named products and jurisdictions, a complete patent estate with expiration timelines, assignees, litigation outcomes, and exclusivity dates cannot be produced without risking factual errors. Per constraints, the response is withheld.